Accuray Inc (ARAY)
1.78
+0.21
(+13.38%)
USD |
NASDAQ |
May 31, 16:00
1.79
+0.01
(+0.56%)
Pre-Market: 20:00
Accuray Price to Book Value: 4.300 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 4.300 |
| May 30, 2024 | 3.793 |
| May 29, 2024 | 3.817 |
| May 28, 2024 | 3.841 |
| May 24, 2024 | 3.648 |
| May 23, 2024 | 3.600 |
| May 22, 2024 | 3.696 |
| May 21, 2024 | 3.672 |
| May 20, 2024 | 3.865 |
| May 17, 2024 | 3.938 |
| May 16, 2024 | 4.034 |
| May 15, 2024 | 4.083 |
| May 14, 2024 | 3.865 |
| May 13, 2024 | 3.817 |
| May 10, 2024 | 3.914 |
| May 09, 2024 | 4.083 |
| May 08, 2024 | 4.034 |
| May 07, 2024 | 4.228 |
| May 06, 2024 | 4.324 |
| May 03, 2024 | 3.914 |
| May 02, 2024 | 3.720 |
| May 01, 2024 | 5.242 |
| April 30, 2024 | 5.146 |
| April 29, 2024 | 5.363 |
| April 26, 2024 | 5.291 |
| Date | Value |
|---|---|
| April 25, 2024 | 5.266 |
| April 24, 2024 | 5.315 |
| April 23, 2024 | 5.363 |
| April 22, 2024 | 5.242 |
| April 19, 2024 | 5.170 |
| April 18, 2024 | 5.339 |
| April 17, 2024 | 5.291 |
| April 16, 2024 | 5.387 |
| April 15, 2024 | 5.580 |
| April 12, 2024 | 5.508 |
| April 11, 2024 | 5.653 |
| April 10, 2024 | 5.726 |
| April 09, 2024 | 5.822 |
| April 08, 2024 | 5.798 |
| April 05, 2024 | 5.798 |
| April 04, 2024 | 5.822 |
| April 03, 2024 | 5.798 |
| April 02, 2024 | 5.870 |
| April 01, 2024 | 5.822 |
| March 31, 2024 | |
| March 28, 2024 | 5.140 |
| March 27, 2024 | 5.057 |
| March 26, 2024 | 4.932 |
| March 25, 2024 | 5.161 |
| March 22, 2024 | 5.182 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.181
Minimum
Mar 24 2020
11.68
Maximum
Nov 04 2021
5.354
Average
5.315
Median
Apr 24 2024
Price to Book Value Benchmarks
| Boston Scientific Corp | 5.576 |
| ResMed Inc | 6.547 |
| Glaukos Corp | 12.60 |
| Perspective Therapeutics Inc | 3.738 |
| Xtant Medical Holdings Inc | 1.966 |
Price to Book Value Related Metrics
| PS Ratio | 0.4025 |
| PEG Ratio | -0.0809 |
| Price | 1.78 |
| Earnings Yield | -12.36% |
| Market Cap | 176.65M |
| PEGY Ratio | -0.0809 |